A Phase 2 Study to Assess the Safety of EI-1071 and the Effects of EI-1071 on Neuroinflammation in Alzheimer's Disease Patients
Elixiron Immunotherapeutics (Hong Kong) Ltd.
Elixiron Immunotherapeutics (Hong Kong) Ltd.
Inmune Bio, Inc.
Inmune Bio, Inc.
Stanford University
University of North Carolina, Chapel Hill
Medical University of South Carolina
Neurologix, Inc.